The thymus represents the ''cradle'' for T cell development, with thymic stroma providing multiple soluble and membrane cues to developing thymocytes. Although IL-7 is recognized as an essential factor for thymopoiesis, the ''environmental niche'' of thymic IL-7 activity remains poorly characterized in vivo. Using bacterial artificial chromosome transgenic mice in which YFP is under control of IL-7 promoter, we identify a subset of thymic epithelial cells (TECs) that co-express YFP and high levels of Il7 transcripts (IL-7 hi cells). IL-7 hi TECs arise during early fetal development, persist throughout life, and co-express homeostatic chemokines (Ccl19, Ccl25, Cxcl12) and cytokines (Il15) that are critical for normal thymopoiesis. In the adult thymus, IL-7 hi cells localize to the cortico-medullary junction and display traits of both cortical and medullary TECs. Interestingly, the frequency of IL-7 hi cells decreases with age, suggesting a mechanism for the age-related thymic involution that is associated with declining IL-7 levels. Our temporal-spatial analysis of IL-7-producing cells in the thymus in vivo suggests that thymic IL-7 levels are dynamically regulated under distinct physiological conditions. This IL-7 reporter mouse provides a valuable tool to further dissect the mechanisms that govern thymic IL-7 expression in vivo.
T
he thymus is the primary organ responsible for the production and selection of T cells, bearing a diverse T cell receptor repertoire restricted to self-MHC molecules and tolerant to selfantigens. Anatomically, it is stratified into two main areas: the outer cortex and the inner medulla. From fetal through postnatal life, hematopoietic progenitors colonize the thymus and undergo a well characterized differentiation program that occurs in distinct thymic niches. CD4 Ϫ CD8 Ϫ double negative (DN) thymocytes committed to the T cell lineage migrate across the cortex, where they undergo an expansion phase and rearrange the T cell receptor (TCR) ␤ genes. Subsequently, CD4 ϩ CD8 ϩ double positive thymocytes that successfully rearranged the TCR ␣ genes are selected to proceed to mature single positive (SP) CD4 ϩ or CD8 ϩ ␣␤ T cells, initiating the reverse migratory path across the cortex toward the medulla. As they move through the corticomedullary junction and into the medulla, they interact with dendritic cells and specialized medullary thymic epithelial cells (mTECs) presenting self-antigens. Auto-reactive T cells are negatively selected, and mature self-tolerant T cells then exit into the periphery (1, 2) .
The T cell developmental pathway is not autonomous and relies on an organized tri-dimensional cellular network of thymic stromal cells composed of dendritic cells (DCs), macrophages, endothelial cells, fibroblasts, and two specialized subsets of TECs: cortical TECs (cTECs) and mTECs (3) . Thymic stroma provides a unique platform of growth factors, chemokines, and receptor ligands that sustain thymocyte survival, proliferation, migration, and differentiation. Compelling evidence suggests a division of labor among the distinct stromal components during different stages of T cell differentiation. Whereas mesenchymal-derived fibroblasts and cTECs are important at early stages of T cell development, mTECs and DCs are critical at later stages governing negative selection and providing survival signals to mature SP thymocytes (3) (4) (5) . Hence, one may envisage that, despite the heterogeneity within the stromal compartment, the different cell types bestow, in a step-wise fashion, specific environmental cues to developing T cells along their migration throughout the thymic stromal cell-made ''avenues'' and in accordance to their requirements.
IL-7 plays a non-redundant role in T cell development. Mice lacking IL-7, IL-7R␣, or ␥ c chains have a marked reduction in ␣␤ T cells and lack ␥␦ T cells (6) (7) (8) . IL-7 belongs to the common cytokine receptor ␥ chain (␥ c ) cytokine family and binds the receptor complex consisting of the IL-7R␣ and ␥ c chains (9) . Despite the invaluable contributions deciphering the biological effects of IL-7 on thymocytes, knowledge of the identity of IL-7-producing cells in vivo, the nature of the distinct anatomical niches in which IL-7 is active, and the regulatory mechanisms that govern its expression remain unclear. In vitro and ex vivo studies have shown that IL-7 transcripts can be detected in multiple cell types and tissues (9) (10) (11) (12) . Yet, the heterogeneity in the IL-7 expression between and within the different cellular subsets hampers the identification of bona fide IL-7-producing cells in vivo. It is conceptually accepted that IL-7 is produced constitutively under steady-state conditions and exists with a limited availability in the body (9, 13) . In parallel, it has been implied that a decrease in IL-7 levels is associated with the age-dependent decline in the production of new T cells, generally known has thymic involution (14, 15) . Thus, a critical unresolved issue in lymphocyte homeostasis is how IL-7 is regulated in vivo.
In this study, we generated a novel reporter mouse that monitors IL-7 expression in vivo. We identified cells co-expressing YFP and high levels of Il7 transcripts (IL -7 hi cells) that constitute a subset of TECs detected during early fetal life and that expressed (in addition to IL-7) other key cytokines and chemokines for T cell development. In the adult thymus, IL-7 hi TECs are positioned at the cortico-medullary junction and bear traits of cortical or medullary TECs. In addition, we provide evidence that IL-7 expression from TECs declines with age, suggesting that IL-7 levels are under tight control in vivo.
Results
Generation of the IL-7 Reporter Mice. To identify IL-7-expressing cells in vivo, we generated transgenic mice carrying a bacterial artificial chromosome (BAC) encoding the YFP under the control of the IL-7 promoter. The YFP gene was inserted by homologous recombination (16) downstream of the ATG trans-lational start codon of exon 1 of the IL-7 locus. The translational stop codon of the YFP coding sequence was retained, thus inactivating the BAC IL-7 protein coding sequence on the BAC. The BAC.IL-7.YFP construct was microinjected into one-cell stage embryos. Five pups had integrated the transgene (screened by PCR analysis of tail DNA), with three showing germ-line transmission of the transgene. YFP expression was screened by immunohistochemistry in fetal and adult thymus, and YFP ϩ cells were detected in progeny of one founder (no. 18201) that is further described in this report. BAC.IL-7.YFP mice appeared healthy, and histological examination of 4-to 8-week-old mice showed normal development of all organs (data not shown). The cellular composition in distinct primary and secondary lymphoid organs showed no significant differences compared with age-matched control mice [supporting information (SI) Fig. S1 ]. (17) . We started by examining YFP(IL-7) expression in the thymus at various gestational stages by using YFP-specific antibodies. YFP(IL-7)-expressing cells (which, for simplicity, we will refer to as IL-7 hi cells) were detected at E14.5-E17.5 with a scattered distribution throughout the thymus. IL-7 hi cells were CD45 Ϫ , indicating a non-hematopoietic origin (Fig. 1A) . We subsequently characterized the nature of this subset by using a panel of markers to distinguish vascular endothelium (CD31), fibroblasts (ERTR7), or TECs (MHC class II) (11, 18) . hi cells lacked markers of endothelial cells (CD31) or fibroblasts (ERTR7), but partially expressed MHC class II (Fig. 1B) . The phenotypic traits of IL-7 hi cells were maintained at E17.5 (Fig. S2) (Fig. 2A) . IL-7
hi cells were further character- ized by using cTEC markers Ly51 and CDR-1 and the mTEC marker lectin Ulex Europaeus Agglutinin (UEA) I (11, 18 hi cells, including the ␥ c cytokine Il15, the homeostatic chemokines Ccl25, Cxcl12, and Ccl19 and the inflammatory chemokines Cxcl10, Tnfsf15, and Ccl5 (Fig. 2D ). Additional analysis confirmed these observations and revealed that transcripts for Notch ligands, such as Dll4 and Jag2, as well as the transcription factor Foxn1, were up-regulated in IL-7 hi cells (data not shown).
Together, our data demonstrate that IL-7 hi cells co-transcribe an array of receptor ligands, cytokines, and chemokines involved in the survival, attraction, proliferation, and maturation of thymocytes.
In the Adult Thymus, IL-7 hi Cells Are Preferentially Localized at the Cortico-Medullary Junction and Bear Markers of Both Cortical and
Medullary TECs. Thymic epithelial patterning is initiated during fetal development and continues throughout postnatal life, with the final acquisition of the typical cortex-medulla compartmentalization achieved in adult life (3, 19) . Given the dynamic nature and continual restructuring of thymic epithelium, we assessed whether IL-7 hi cells preserved their lineage origin after birth. IL-7 hi cells were present in postnatal thymus, displayed TEC traits similar to their fetal thymic counterparts (CD45
, and clearly expressed abundant Il7 transcripts. TECs that lack YFP also expressed Il7, although at lower levels than IL-7 hi TECs ( Fig. 2 E and F and Fig. S3 ). These data indicate that this reporter mouse identifies TECs that express abundant Il7 transcripts and suggests the existence of heterogeneity of IL-7 expression within TECs.
The spatial location and phenotype of IL-7 hi cells in adult thymus cells were characterized. IL-7 hi cells were predominantly localized at the cortico-medullary junction and inside the medulla, defined either by nuclear staining (with DAPI) or MTS33 staining. Note that DAPI staining defines high and low cellular density areas of the cortex and medulla, respectively, and MTS33 stains cortical but not medullary thymocytes and small clusters of medullary epithelial cells (Fig. 3A) (20) . Thus, IL-7 hi cells are strategically positioned at an anatomical site favorable for interactions with thymocytes at both early and late stages of their development (5) .
Analysis of Il7 mRNA levels in adult thymic stromal subsets revealed that cortical and medullary TECs were the two predominant IL-7-expressing subsets (Fig. S4A) . Accordingly, we found that adult thymic IL-7 hi cells lacked markers of hematopoietic cells (CD45), endothelial cells (CD31), and fibroblasts (ERTR7; 
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Fold differences relative mRNA levels ϩ UEA Ϫ MTS10 Ϫ , whereas those proximal to the medulla were CDR-1 Ϫ Ly51 Ϫ MTS10 ϩ UEA Ϫ (Fig.  3B) . Together, our results indicate that, in adult thymus, IL-7 hi cells comprise at least two specialized subsets bearing traits of either cortical or medullary TECs.
YFP ؉ (IL-7 hi ) Cells Are Not Detected in the Periphery of BAC.IL-7.YFP
Transgenic Mice. Apart from its role in thymocyte development, IL-7 is also critical for the control of peripheral T cell homeostasis and B cell development (7, 8, 21) . We therefore examined BAC.IL-7.YFP reporter mice for IL-7 hi cells outside of the thymus. Histological and flow cytometric analyses of 3-to 8-week-old mice showed that YFP ϩ cells were not detected in the bone marrow and secondary lymphoid organs, including spleen and peripheral lymph nodes (data not shown). A probable explanation for this result is that our reporter mouse may not faithfully read-out the complete range of IL-7 expression in vivo. Previous studies have identified Il7 transcripts in several cell types, including lymph node reticular cells, thymic DC cells, and fibroblast and gut epithelial cells (9) (10) (11) (12) . We hypothesized that these cells might have lower IL-7 expression compared with thymic IL-7 hi TECs that we are able to visualize in BAC.IL-7.YFP transgenic mice. The glycoprotein gp38 defines a population of IL-7-expressing fibroblast reticular cells in the lymph nodes (10) . We therefore compared Il7 mRNA expression levels from sorted thymic IL-7 ϩ TECs and gp38 ϩ fibroblastic lymph node reticular cells. We found that Il7 transcripts were more strongly expressed in IL-7 hi TECs compared with gp38 ϩ fibroblasts (Fig.  S4B) . Thus, it is likely that our reporter mouse can clearly identify only cells expressing high IL-7 levels.
The Frequency of Thymic IL-7 hi Cells Declines with Age. Thymic involution has been associated with a decline in IL-7 levels (14, 15). These changes appear to affect and/or be affected by the cellular composition of the thymic stroma. To address whether the agedependent decline in T cell production was associated with alterations in IL-7 hi TECs, we analyzed YFP expression in TECs of mice at different ages. As shown in Fig. 4A , and in accordance with previous studies (18) , the number of CD45 ϩ cells reached their maximum between 2 and 7 weeks, followed by a conspicuous decline. Although both TECs subsets-MHCII ϩ YFP ϩ and MHCII ϩ YFP Ϫ -showed a similar pattern of age-related loss, the reduction in IL-7 hi cells was more profound (Fig. 4 B-D) . These data provide in vivo evidence that the decline in T cell production with age may be a consequence of a diminution in TECs that express high levels of IL-7.
Discussion
Despite the accumulating knowledge on the biological effects of IL-7 during thymopoiesis, the precise identity of IL-7-expressing cells in vivo has eluded immunologists. It has been proposed that thymic stromal components are the source of IL-7 (19, 22) . Yet, the lack of means to specifically identify IL-7-expressing cells precludes the resolution of important issues in fundamental immunology, such as their developmental lineage, anatomical location, and associated functional characteristics. Here, we describe an IL-7 reporter mouse that allowed us to identify and characterize TECs expressing high levels of IL-7. Our data provide evidence that IL-7 hi cells are confined to a TEC subset detected during early fetal development and that persist throughout postnatal life. In the adult thymus, IL-7 hi cells are predominantly localized at the cortico-medullary junction and display features of cortical or medullary TECs.
The thymus starts to be colonized by hematopoietic progenitors by days 11 to 12 of gestation (23) . Over the next 2 days, IL-7-dependent T cell precursors (DN2 and DN3, defined as CD44 ϩ CD25 ϩ and CD44 Ϫ CD25 ϩ ) are first observed (24), suggesting that IL-7 expression is initiated during this period. Interestingly, in association with the presumable need for IL-7, IL-7 hi cells were detected within this time frame (after E13.5; Figs. 1 and 2 ). Our data strongly suggest that this subset comprise a population of IL-7-expressing TECs. First, Il7 transcripts were markedly upregulated in YFP ϩ cells (Fig. 2) . Second, IL-7 hi cells were of non-hematopoietic origin (CD45 Ϫ ), lacked endothelial and mesenchymal markers, and expressed TEC markers throughout development, including MHC class II, Ly51, and CDR1 ( Figs. 1 and 2) . Last, transcripts for Foxn1, a transcription factor crucial for TEC differentiation (25) , were up-regulated in IL-7 hi cells, corroborating a TEC signature (data not shown). Interestingly, various transcripts for homeostatic cytokines, chemokines, and receptor ligands that are critical for T cell development were found to be co-expressed in IL-7 hi cells ( Fig. 2 and data not shown). These included the chemokines CCL25 (thymus-expressed chemokine) and CXCL12 (stromal cell-derived factor-1), which are important for the recruitment of hematopoietic progenitors into the thymus, and the ligands for FMS-like tyrosine kinase 3 receptor and Notch receptors, which are important for the survival and commitment of early T cell precursors (26) . Based on these results, it is possible that IL-7 hi TECs may play a broader role at early stages of thymopoesis.
The complete patterning of the thymus, typified by the segregation into cortex and medulla, is a dynamic process initiated during fetal life and ultimately achieved in adulthood (19) . In the fetal thymus, IL-7 hi cells were found scattered in the fetal thymus. Interestingly, however, in the adult thymus this subset was strategically positioned at the cortico-medullary region, bearing traits of cortical (Ly51 (Fig. 3) . Concordantly, in the adult thymus, Il7 transcripts were predominantly expressed in fractionated cortical and medullary TECs (Fig. S4A ). These observations suggest the existence of two hi TEC subsets within the adult thymus. Compelling evidence has shed light on the lineage relationships between cortical and medullary TECs. It is currently accepted that these two subsets are derived from a common epithelial progenitor (27) (28) (29) . Given the anatomical location and the exclusive expression of either cortical or medullary markers, it remains to be addressed whether cortical and medullary IL-7 hi cells constitute intermediate progenitor subsets of mature cTECs and mTECs, respectively.
Conceptual models propose that distinct stromal components play specialized roles nurturing thymocytes, in a step-wise fashion, with various environmental cues that sustain their commitment (Notch ligands), survival (IL-7), migration (thymus-expressed chemokine, stromal cell-derived factor-1, CCL19, and CCL21), and selection (promiscuous gene expression by AIRE ϩ mTECs) (2, 3, 5, 19) . It is interesting to note that the anatomical location of cells expressing high levels of IL-7 is strikingly associated with the requirements for IL-7 by thymocytes at different stages of differentiation. IL-7-derived survival and proliferative signals are needed by early T cell precursors positioned in inner part of the cortex for the DN2-DN3 transition and by SP mature T cells located in the medulla (6, 30) . In this regard, we postulate a division of labor among IL-7 hi cells, such that the IL-7 hi CDR1 ϩ LY51 ϩ MTS10 Ϫ and IL-7 hi CDR1 Ϫ Ly51 Ϫ MTS10 ϩ TECs are responsible for nurturing thymocytes at early and late stages of development, respectively.
Thymic stromal lymphopoietin (TSLP), another IL-7-like cytokine (31), appears to be expressed by human epithelial cells of Hassall corpuscle in the thymic medulla (32) . Despite their close biological activities (33), we found that TSLP was not enriched in IL-7 hi cells (data not shown), suggesting that IL-7 and TSLP niches may be cellular and anatomical distinct. Both IL-7 and TSLP play also an important role in B cell development and peripheral T cell homeostasis (7, 8, 21, 33 ). Yet, a comprehensive analysis of normal BAC.IL-7.YFP transgenic mice in multiple lymphoid organs has so far unsuccessfully revealed any YFP ϩ cells in anatomical locations other than the thymus. It is likely that this novel reporter mouse may identify only cells expressing high levels of IL-7 ( Fig. 2 and Fig. S4) , which explains the lack of YFP expression in other organs. This observation may be associated with distinct physiological context, which reflects a putative lower triggering threshold for IL-7 in peripheral mature T cells.
Thymic involution is associated with reduction in T cell output. It has been proposed that diminishing IL-7 level is associated with the decrease in T cell generation, although experimental evidence is limited (14, 15) . Our results suggest there is heterogeneity in IL-7 expression within TECs (Fig. 2E) and alterations in the dynamic of IL-7-expressing TEC populations with time. Particularly, the number of thymic IL-7 hi cells diminishes with age, and remarkably, this begins as early as 5 to 7 weeks of age. Although an overall decrease in the stromal cellularity was noted, in line with previous observations (18) , we found that the frequency of YFP ϩ (IL-7 hi ) TECs declined at a faster rate compared than YFP Ϫ TECs (Fig. 4) . It remains to be answered whether the reduction in IL-7
hi TECs is a cause or consequence of thymic involution, and whether the age-associated decrrease in their density is reflected by a decrease in the functional capacity to transcribe Il7 or by impaired turnover of this specialized subset.
In conclusion, our data provide a precise anatomical and phenotypical characterization of IL-7-expressing TECs in the thymus in vivo. The identification of a thymic IL-7-dependent ''niche'' will provide the opportunity to address questions concerning the interaction between different lymphocyte populations with IL-7-producing cells in normal and pathological settings. This reporter mouse provides an unique tool to survey the major IL-7-producing cells. Moreover, further transcriptional analysis of cells expressing high levels of IL-7 should provide a framework to gain insights into the molecular mechanisms that regulate its expression. Understanding the rules that govern IL-7 expression will have important implications for therapies that aim to boost T cell development and/or homeostasis through increased IL-7 availability. 
